Atul Butte, MD, PhD
Director & Distinguished Professor, Institute for Computational Health Sciences
University of California, San Francisco
Atul Butte, MD, PhD is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and Director of the Institute for Computational Health Sciences (ichs.ucsf.edu) at the University of California, San Francisco (UCSF). Dr. Butte has authored over 200 publications, with research repeatedly featured in the New York Times and Wall Street Journal. Dr. Butte was elected into the National Academy of Medicine in 2015, and was recognized by the Obama Administration as an Open Science Champion of Change in 2013 for promoting open data. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis, providing medical genome sequencing services, Carmenta (acquired by Progenity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte is a principal investigator of the California Initiative to Advance Precision Medicine and the California Precision Medicine Consortium, recruiting thousands of participants into President Obama’s Precision Medicine Initiative.